About this Event
Beyond PSMA Lutetium Approval: the Unanswered Questions
Organizer: Eric Small, MD
This workshop will be an online event open to registered attendees. Presentation topics will cover clinical implications of approval for 177Lu-PSMA-617, modulation of PSMA expression, PSMA-lutetium and immunotherapy, and PSMA-targeted alpha particle therapy.
- Louise Emmett, MD
Professor, University of New South Wales
Director, Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney
Mix ‘n Match: Optimizing PSMA Targeted Therapy.... Or Not?
- Vadim Koshkin, MD
PSMA-Lutetium: Clinical Implications and Unanswered Questions
- Luke Gilbert, PhD and Vadim Koshkin, MD
Regulation of PSMA Expression and Clinical Implications
- Rahul Aggarwal, MD
Clinical Trial: PSMA-Lutetium and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
- Lawrence Fong, MD
CyTOF Results from PSMA-Lutetium and Pembrolizumab Trial
- Thomas Hope, MD
Beyond Lutetium: PSMA-Actinium
Open to the UCSF research community. Please register to attend by Nov 15.